Vanguard disaggregates holdings; reports zero ownership in Integra (IART)

Rhea-AI Filing Summary

Integra LifeSciences Holdings Corp Schedule 13G/A: The Vanguard Group filed an amendment reporting 0 shares beneficially owned and 0% of the common stock as of the amendment. The filing states Vanguard implemented an internal realignment on January 12, 2026 and is reporting certain subsidiaries separately in reliance on SEC Release No. 34-39538.

The amendment is signed by a Vanguard officer and explains that subsidiaries or business divisions that formerly were reported with The Vanguard Group will now report disaggregated ownership; Vanguard states it no longer is deemed to beneficially own securities held by those subsidiaries.

Insights

Institutional Ownership Analyst

Disaggregation reduced Vanguard's reported stake to zero in this filing.

The amendment documents an internal reorganization dated January 12, 2026 and reports 0 shares and 0% beneficial ownership in Integra common stock. The filing relies on SEC Release No. 34-39538 to justify separate reporting by Vanguard subsidiaries.

Operationally, this is an administrative disclosure about reporting format and not an economic transaction in Integra shares; subsequent filings by the named subsidiaries may show beneficial positions.

Corporate Governance Specialist

Amendment clarifies reporting responsibility, not a change in underlying custody or strategy.

The text states subsidiaries pursue the same investment strategies as before the realignment and that Vanguard no longer is deemed to beneficially own securities held by those units under the cited SEC release. The signatory is identified as Head of Global Fund Administration.

For a full ownership picture, review later disaggregated 13G/A filings from the specified Vanguard entities; this filing itself reports no holdings.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 10)

Integra LifeSciences Holdings Corp

(Name of Issuer)

Common Stock

(Title of Class of Securities)

(CUSIP Number)

03/13/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP No.

1

Names of Reporting Persons

The Vanguard Group

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Integra LifeSciences Holdings Corp
(b)	Address of issuer's principal executive offices: 1100 Campus Road, Princeton, NJ, 08540
Item 2.
(a)	Name of person filing: The Vanguard Group
(b)	Address or principal business office or, if none, residence: 100 Vanguard Blvd.,, Malvern, PA, 19355
(c)	Citizenship: PA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.:
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0
(b)	Percent of class: 0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The Vanguard Group, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.No one other person's interest in the securities reported herein is more than 5%.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

The Vanguard Group

Signature:	Ashley Grim
Name/Title:	Head of Global Fund Administration
Date:	03/27/2026

FAQ

What does Vanguard report for IART ownership in this 13G/A?

Vanguard reports 0 shares beneficially owned and 0% of Integra's common stock. The amendment states Vanguard is disaggregating reporting after an internal realignment effective January 12, 2026.

Why does Vanguard say its ownership is zero for IART?

The filing explains an internal realignment on January 12, 2026 that led certain subsidiaries to report separately. Vanguard states it no longer is deemed to beneficially own securities reported by those subsidiaries in reliance on SEC Release No. 34-39538.

Does this filing indicate Vanguard sold Integra (IART) shares?

No. The amendment describes a reporting change due to internal reorganization and separate subsidiary reporting; it does not state any sale or purchase of Integra shares by Vanguard in this filing.

Who signed the amendment for Vanguard on the 13G/A?

The amendment is signed by Ashley Grim, Head of Global Fund Administration, with a signature date of 03/27/2026, per the filing's signature block.

Will Vanguard subsidiaries now report their IART holdings separately?

Yes. The filing states certain subsidiaries or business divisions will report beneficial ownership separately and pursue the same investment strategies previously reported under The Vanguard Group, Inc., per SEC Release No. 34-39538.